News

SkyePharma said it had agreed the main terms of a deal to help develop and market the respiratory medicine with an undisclosed party. The $160 million will include

It is common for patients in heart failure to show cognitive dysfunction, known in the past as cardiogenic dementia. However, by evaluating and treating some coexisting conditions observed

Five monkeys infected with simian immunodeficiency virus (SIV), a very close relative of HIV, and treated with minocycline had less damage to brain cells, less brain inflammation, and

The study, published in the journal Science Express, provides insight into understanding how infectious parasites interface with the immune system – a problem of great scientific and clinical

Velcade (bortezomib) for injection is indicated as monotherapy for use in patients who have received at least one prior therapy and who have already undergone or are unsuitable

The successful results of a North American study, presented earlier this week, have now been replicated in a large-scale study involving 39 different countries. Interim analysis of phase

The drugs, Paxil CR, an antidepressant tablet and Avandamet, a diabetes medication, were seized following an FDA inspection which revealed manufacturing problems at the plant. Glaxo believes it

The US District Court has rescheduled opening arguments from May 9, 2005 to December 5, 2005 for the trial, related to patent litigation regarding the selective serotonin reuptake

MX-4509 is an orally-administered drug candidate being developed for the treatment of neurodegenerative diseases. It was well tolerated in a phase I clinical trial and has demonstrated neuroprotective